Loss of Alkalization in Proximal Esophagus: A New Diagnostic Paradigm for Patients with Laryngopharyngeal Reflux

Journal of Gastrointestinal Surgery

Volumn 14, Issue 11, 2010, Pages 1653-1659

  Ayazi, Shahin ^a   Hagen, Jeffrey A ^a   Zehetner, Joerg ^a   Lilley, Matt ^a   Wali, Priyanka ^a   Augustin, Florian ^a   Oezcelik, Arzu ^a   Sohn, Helen J ^a   Lipham, John C ^a   DeMeester, Steven R ^a   DeMeester, Tom R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Diagnosis; Diagnostic test; Esophageal pH monitoring; Esophagus; Gastroesophageal reflux disease (GERD); Laryngopharyngeal reflux (LPR); pH Monitoring; Pharynx; Sensitivity

Indexed keywords

ADULT; AGED; ARTICLE; ESOPHAGEAL PH MONITORING; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; ESOPHAGEAL PH MONITORING; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; REGURGITATION, GASTRIC; YOUNG ADULT;

EID: 77958495781     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1327-3     Document Type: Article

References (28)

1. Shaker R, Mibrath M, Ren J, Toohill R, Hogan WJ, Li Q, Hofmann CL: Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 109: 1575-1582, 1995.
2. Patti MG, Debas HT, Pellegrini C: Esophageal manometry and 24-hour pH monitoring in the diagnosis of pulmonary aspiration secondary to gastroesophageal reflux. Am J Surg 163: 401-406, 1992.
3. Ekstrom T, Tibbling L. Gastro-oesophageal reflux and triggering of bronchial asthma: A negative report. Eur J Respir Dis. 71: 177-180, 1987.
4. Gastal OL, Castell JA, Castell DO: Frequency and site of gastroesophageal reflux in patients with chest symptoms: Studies using proximal and distal pH monitoring. Chest 106: 1793-1796, 1994.
5. Waring JP, Lacayo L, Hunter JG, Katz E, Suwak B: Chronic cough and hoarseness in patients with severe gastroesophageal disease: Diagnosis and response to therapy. Dig Dis Sci 40: 1093-1097, 1995.
6. Harding SM, Richter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA: Asthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcome. Am J Med 100: 395-405, 1996.
7. Schnatz PF, Castell JA, Castell DO: Pulmonary symptoms associated with gastroesophageal reflux: Use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol 91(9): 1715-1718, 1996.
8. Paterson WG, Murat BW: Combined ambulatory esophageal manometry and dual-probe pH-metry in the evaluation of patients with chronic unexplained cough. Dig Dis Sci 39(5): 1117-1125, 1994.
9. Ayazi S, Hagen JA, Zehetner J, et al. Proximal esophageal pH monitoring: improved definition of normal values and determination of a composite pH score. J Am Coll Surg. 2010 Mar; 210(3): 345-50.
10. Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997; 92(5): 825-9.
11. Bulmer DM, Ali MS, Brownlee IA, Dettmar PW, Pearson JP. Laryngeal mucosa: its susceptibility to damage by acid and pepsin. Laryngoscope. 2010 Apr; 120 (4): 777-82.
12. Samuels TL, Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg. 2009; 141(5): 559-63.
13. Johnston N, Bulmer D, Gill GA, Panetti M, Ross PE, Pearson JP, Pignatelli M, Axford SE, Dettmar PW, Koufman JA. Cell biology of laryngeal epithelial defenses in health and disease: further studies. Ann Otol Rhinol Laryngol. 2003; 112(6): 481-91.
14. Johnston N, Dettmar PW, Bishwokarma B, Lively MO, Koufman JA. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope. 2007 Jun; 117(6): 1036-9.
15. Zaninotto G, DeMeester TR, Schwizer W, et al. The lower esophageal sphincter in health and disease. AmJ Surg 1988; 155: 104-111.
16. Ayazi S, Leers JM, Oezcelik A, et al. Measurement of gastric pH in ambulatory esophageal pH monitoring. Surg Endosc 2009; 23: 1968-1973.
17. Bray GW. Recent advances in the treatment of asthma and hay fever. Practitioner 1934; 34: 368-71.
18. Cherry J, Margulies SI. Contact ulcer of the larynx. Laryngoscope. 1968 Nov; 78(11): 1937-40.
19. Qadeer MA, Phillips CO, Lopez AR et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006 Nov; 101(11): 2646-54.
20. Ayazi S, Demeester TR. Surgical Antireflux Therapy for Patients with Extraesophageal Reflux. In Johnston N and Toohill J, eds. Effects, Diagnosis and Management of Extra-Esophageal Reflux. ISBN: 978-1-61668-177-7.
21. Mahieu HF. The laryngological manifestations of reflux disease; why the scepticism? Aliment Pharmacol Ther 2007: 26: 17-24.
22. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101: 1-7.
23. Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002; 16: 564-579.
24. Tylenda CA, Ship JA, Fox PC, Baum BJ. Evaluation of submandibular salivary flow rate in different age groups. J Dent Res. 1988 Sep; 67(9): 1225-8.
25. Ship JA, Nolan NE, Puckett SA. Longitudinal analysis of parotid and submandibular salivary flow rates in healthy, different-aged adults. J Gerontol A Biol Sci Med Sci. 1995; 50(5): M285-9.
26. Samuels TL, Johnston N. Pepsin as a marker of extraesophageal reflux. Ann Otol Rhinol Laryngol. 2010 Mar; 119(3): 203-8.
27. Eckley CA, Costa HO. Comparative study of salivary pH and volume in adults with chronic laryngopharyngitis by gastroesophageal reflux disease before and after treatment. Braz J Otorhinolaryngol. 2006; 72(1): 55-60.
28. Kongara KR, Soffer EE. Saliva and esophageal protection. Am J Gastroenterol 1999; 94(6): 1446-52.